Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
National Cancer Institute (NCI)
Northwestern University
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Therapeutic Advances in Childhood Leukemia Consortium
SWOG Cancer Research Network
Barbara Ann Karmanos Cancer Institute
GlaxoSmithKline
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
University of Washington